Full Name
Albert Chan
Job Title
Professor
Company/Institution/ Organization
The University of Hong Kong
Speaker Bio
Professor Chan is the Li Shu Fan Medical Foundation Professor in Surgery. He is the Director of the Liver Transplant Center at Queen Mary Hospital and the Deputy Chairperson of the Department of Surgery, The University of Hong Kong.
Professor Chan was recently elected to be the Honorary Member of the European Surgical Association (ESA). He also served as the President of the Asian Surgical Association from 2015 to 2017 and as the Chairman of the Vanguard Committee at the International Liver Transplant Society (ILTS) from 2019 to 2021. He has held various positions in committees at the International Hepato-Pancreato-Biliary Association (IHPBA) and the Asia-Pacific Hepato-Pancreato-Biliary Association (A-PHPBA) including the Scientific Committee, Research Committee, Education and Training Committee, and Publication and Communication Committee, as well as being the founding member for International Laparoscopic Liver Surgery (ILLS), and member-at-large at the International Society of Liver Surgeons (ISLS)
His research interests focus on the treatment for hepatocellular carcinoma and transplant oncology. Notably, he pioneered the use of combination approach using a tri-modality therapy (TACE+SBRT+IO) to downstage locally advanced liver cancer for transplantation or surgery, known as the START-FIT strategy. Besides, he has extensive experience in complex liver surgery including Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) procedure, particularly for hepatocellular carcinoma. He also performed the world's first ALPPS in a child with hepatoblastoma in 2013 and co-edited the first book on ALPPS in China. More recently, he performed the first Liver Histotripsy in Asia in September 2024 and has now accrued the largest experience outside the US.
As an academic scholar, Professor Chan was ranked the World’s Top 2% scientists by Stanford University in 2024 and was awarded the Dr. Abdol and Mrs. Joan Islami International Guest Scholar by the American College of Surgeons in 2018. His innovative work in downstaging treatment for liver cancer has also won him a special grand prize awarded by the delegate of Malaysia and a Silver Medal at the 49th Geneva International Exhibition of Inventions. He has authored 8 book chapters and published over 300 peer-reviewed articles with some notable publications in esteemed journals such as Lancet Oncology, Lancet Gastroenterology and Hepatology, JAMA Oncology and Annals of Surgery. He serves on the editorial boards of Annals of Surgery and Hepatobiliary and Surgical Nutrition. Throughout his career, he has successfully secured a series of grants from the RGC, mainland funding agencies, and industry support, totalling over $10 million USD.
Professor Chan was recently elected to be the Honorary Member of the European Surgical Association (ESA). He also served as the President of the Asian Surgical Association from 2015 to 2017 and as the Chairman of the Vanguard Committee at the International Liver Transplant Society (ILTS) from 2019 to 2021. He has held various positions in committees at the International Hepato-Pancreato-Biliary Association (IHPBA) and the Asia-Pacific Hepato-Pancreato-Biliary Association (A-PHPBA) including the Scientific Committee, Research Committee, Education and Training Committee, and Publication and Communication Committee, as well as being the founding member for International Laparoscopic Liver Surgery (ILLS), and member-at-large at the International Society of Liver Surgeons (ISLS)
His research interests focus on the treatment for hepatocellular carcinoma and transplant oncology. Notably, he pioneered the use of combination approach using a tri-modality therapy (TACE+SBRT+IO) to downstage locally advanced liver cancer for transplantation or surgery, known as the START-FIT strategy. Besides, he has extensive experience in complex liver surgery including Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) procedure, particularly for hepatocellular carcinoma. He also performed the world's first ALPPS in a child with hepatoblastoma in 2013 and co-edited the first book on ALPPS in China. More recently, he performed the first Liver Histotripsy in Asia in September 2024 and has now accrued the largest experience outside the US.
As an academic scholar, Professor Chan was ranked the World’s Top 2% scientists by Stanford University in 2024 and was awarded the Dr. Abdol and Mrs. Joan Islami International Guest Scholar by the American College of Surgeons in 2018. His innovative work in downstaging treatment for liver cancer has also won him a special grand prize awarded by the delegate of Malaysia and a Silver Medal at the 49th Geneva International Exhibition of Inventions. He has authored 8 book chapters and published over 300 peer-reviewed articles with some notable publications in esteemed journals such as Lancet Oncology, Lancet Gastroenterology and Hepatology, JAMA Oncology and Annals of Surgery. He serves on the editorial boards of Annals of Surgery and Hepatobiliary and Surgical Nutrition. Throughout his career, he has successfully secured a series of grants from the RGC, mainland funding agencies, and industry support, totalling over $10 million USD.
Speaking At
